Fundz

Vergent Bioscience

MINNEAPOLIS, Minnesota, United States · Biotechnology, Health Care, Therapeutics

Vergent Bioscience is a clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by significantly improving the visibility of tumors. Vergent’s lead compound, VGT-309, is a tumor-targeted fluorescent imaging agent intentionally designed to enable surgeons to see previously undetected or difficult-to-find tumors d

You have opened 5 full company profiles today. Create an account to keep reading them. Create an account

Key facts

Headquarters
MINNEAPOLIS, Minnesota, United States
Employees
Unknown
Industries
Biotechnology, Health Care, Therapeutics
Status
Private
Website
vergentbio.com
LinkedIn
Company page

Recent activity at Vergent Bioscience

About Vergent Bioscience: questions and answers

What does Vergent Bioscience do?

Vergent Bioscience is a clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by significantly improving the visibility of tumors. Vergent’s lead compound, VGT-309, is a tumor-targeted fluorescent imaging agent intentionally designed to enable surgeons to see previously undetected or difficult-to-find tumors d

Where is Vergent Bioscience headquartered?

Vergent Bioscience is headquartered in MINNEAPOLIS, Minnesota, United States.

What is the latest news on Vergent Bioscience?

On Jun 09, 2026, Vergent Bioscience Appoints Adam Gridley as Chief Executive Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Vergent Bioscience across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.